Abstract
Topoisomerases I promote the relaxation of DNA superhelical tension by introducing a transient single-stranded break in duplex DNA and are vital for the processes of replication, transcription, and recombination. The crystal structures at 2.1 and 2.5 angstrom resolution of reconstituted human topoisomerase I comprising the core and carboxyl-terminal domains in covalent and noncovalent complexes with 22–base pair DNA duplexes reveal an enzyme that “clamps” around essentially B-form DNA. The core domain and the first eight residues of the carboxyl-terminal domain of the enzyme, including the active-site nucleophile tyrosine-723, share significant structural similarity with the bacteriophage family of DNA integrases. A binding mode for the anticancer drug camptothecin is proposed on the basis of chemical and biochemical information combined with these three-dimensional structures of topoisomerase I–DNA complexes.
References
81
Referenced
715
- J. J. Champoux in DNA Topology and Its Biological Effects J. C. Wang and N. R. Cozzarelli Eds. (Cold Spring Harbor Laboratory Cold Spring Harbor NY 1990) pp. 217–242;
10.1146/annurev.bi.65.070196.003223
- ; J. J. Champoux Prog. Nucleic Acids Res. Mol. Biol. in press.
-
Lue N., Sharma A., Mondragon A., Wang J. C., Structure 3, 1315 (1995).
(
10.1016/S0969-2126(01)00269-6
) / Structure by Lue N. (1995) - Sharma A., Hanai R., Mondragon A., ibid. 2, 767 (1994). / ibid. by Sharma A. (1994)
-
Lima C. D., Wang J. C., Mondragón A., Nature 367, 138 (1994);
(
10.1038/367138a0
) / Nature by Lima C. D. (1994) - Berger J. M., Gamblin S. J., Harrison S. C., Wang J. C., ibid. 380, 179 (1996). / ibid. by Berger J. M. (1996)
-
Wang H.-K., Morris-Natschke S. L., Lee K.-H., Med. Res. Rev. 17, 367 (1997).
(
10.1002/(SICI)1098-1128(199707)17:4<367::AID-MED3>3.0.CO;2-U
) / Med. Res. Rev. by Wang H.-K. (1997) -
Shaffer R., Traktman P., J. Biol. Chem. 262, 9309 (1987).
(
10.1016/S0021-9258(18)48081-7
) / J. Biol. Chem. by Shaffer R. (1987) -
Shuman S., Moss B., Proc. Natl. Acad. Sci. U.S.A. 84, 7478 (1987).
(
10.1073/pnas.84.21.7478
) / Proc. Natl. Acad. Sci. U.S.A. by Shuman S. (1987) -
Gupta M., Fujimori A., Pommier Y., Biochim. Biophys. Acta 1262, 1 (1995);
(
10.1016/0167-4781(95)00029-G
) / Biochim. Biophys. Acta by Gupta M. (1995) -
Caron P. R., Wang J. C., Adv. Pharmacol. 29B, 271 (1994).
(
10.1016/S1054-3589(08)61143-6
) / Adv. Pharmacol. by Caron P. R. (1994) - The crystal structures of two proteolytic fragments of topo I have been reported from vaccinia (3) and yeast (2). However these structures represent relatively small (9 and 26 kD respectively) NH 2 -terminal fragments of the enzyme that do not contain active-site residues or bound DNA.
-
P. D′Arpa et al. Proc. Natl. Acad. Sci. U.S.A. 85 2543 (1988).
(
10.1073/pnas.85.8.2543
) -
Stewart L., Ireton G. C., Parker L. H., Madden K. R., Champoux J. J., J. Biol. Chem. 271, 7593 (1996).
(
10.1074/jbc.271.13.7593
) / J. Biol. Chem. by Stewart L. (1996) - L. Stewart G. C. Ireton J. J. Champoux ibid. p. 7602.
- Alsner J., Svejstrup J. Q., Kjeldsen E., Sorensen B. S., Westergaard O., ibid. 267, 12408 (1992). / ibid. by Alsner J. (1992)
-
A. K. Bharti M. O. Olson D. W. Kufe E. H. Rubin ibid. 271 1993 (1996).
(
10.1074/jbc.271.4.1993
) - Madden K. R., Champoux J. J., Cancer Res. 52, 525 (1992). / Cancer Res. by Madden K. R. (1992)
-
Stewart L., Ireton G. C., Champoux J. J., J. Mol. Biol. 269, 355 (1997).
(
10.1006/jmbi.1997.1056
) / J. Mol. Biol. by Stewart L. (1997) - The reconstituted enzyme is more sensitive to ionic strength and more distributive in its mode of action than the full-length enzyme (16 20).
-
Been M. D., Burgess R. R., Champoux J. J., Nucleic Acids Res 12, 3097 (1984).
(
10.1093/nar/12.7.3097
) / Nucleic Acids Res by Been M. D. (1984) - Andersen A. H., Gocke E., Bonven B. J., Nielsen O. F., Westergaard O., ibid. 13, 1543 (1985). / ibid. by Andersen A. H. (1985)
10.1126/science.279.5356.1534
-
M. E. Wall et al. J. Am. Chem. 88 3888 (1966);
(
10.1021/ja00968a057
) - Horwitz S. B., Chang C. K., Grollman A. P., Mol. Pharmacol. 7, 632 (1971). / Mol. Pharmacol. by Horwitz S. B. (1971)
-
Hsiang Y. H., Hertzberg R., Hecht S., Liu L. F., J. Biol. Chem. 260, 14873 (1985).
(
10.1016/S0021-9258(17)38654-4
) / J. Biol. Chem. by Hsiang Y. H. (1985) - Bjornsti M. A., Benedetti P., Viglianti G. A., Wang J. C., Cancer Res. 49, 6318 (1989). / Cancer Res. by Bjornsti M. A. (1989)
-
Hertzberg R. P., et al., J. Med. Chem. 32, 715 (1989).
(
10.1021/jm00123a038
) / J. Med. Chem. by Hertzberg R. P. (1989) -
S. Sawada et al. Chem. Pharmacol. Bull. 39 3183 (1991).
(
10.1248/cpb.39.3183
) -
Porter S. E., Champoux J. J., Nucleic Acids Res. 17, 8521 (1989).
(
10.1093/nar/17.21.8521
) / Nucleic Acids Res. by Porter S. E. (1989) -
Hertzberg R. P., Caranfa M. J., Hecht S. M., Biochemistry 28, 4629 (1989);
(
10.1021/bi00437a018
) / Biochemistry by Hertzberg R. P. (1989) -
Svejstrup J. Q., Christiansen K., Gromova I. I., Andersen A. H., Westergaard O., J. Mol. Biol. 222, 669 (1991).
(
10.1016/0022-2836(91)90503-X
) / J. Mol. Biol. by Svejstrup J. Q. (1991) -
Hertzberg R. P., et al., J. Biol. Chem. 265, 19287 (1990).
(
10.1016/S0021-9258(17)30656-7
) / J. Biol. Chem. by Hertzberg R. P. (1990) -
Bendixen C., Thomsen B., Alsner J., Westergaard O., Biochemistry 29, 5613 (1990).
(
10.1021/bi00475a028
) / Biochemistry by Bendixen C. (1990) - Hsiang Y. H., Lihou M. G., Liu L. F., Cancer Res. 49, 5077 (1989). / Cancer Res. by Hsiang Y. H. (1989)
- Benedetti P., Fiorani P., Capuani L., Wang J. C., ibid. 53, 4343 (1993); / ibid. by Benedetti P. (1993)
-
Knab A. M., Fertala J., Bjornsti M. A., J. Biol. Chem. 268, 22322 (1993);
(
10.1016/S0021-9258(18)41531-1
) / J. Biol. Chem. by Knab A. M. (1993) - Rubin E., et al., ibid. 269, 2433 (1994); / ibid. by Rubin E. (1994)
- Wang L. F., et al., Cancer Res. 57, 1516 (1997); / Cancer Res. by Wang L. F. (1997)
-
Tamura H., et al., Nucleic Acids Res. 19, 69 (1991);
(
10.1093/nar/19.1.69
) / Nucleic Acids Res. by Tamura H. (1991) -
Tanizawa A., et al., J. Biol. Chem. 268, 25463 (1993);
(
10.1016/S0021-9258(19)74414-7
) / J. Biol. Chem. by Tanizawa A. (1993) -
Kubota N., et al., Biochem. Biophys. Res. Commun. 188, 571 (1992);
(
10.1016/0006-291X(92)91094-7
) / Biochem. Biophys. Res. Commun. by Kubota N. (1992) - ; X. G. Li et al. Bioch. Pharmacol. 53 1019 (1997).
-
Leteurtre F., et al., J. Biol. Chem. 269, 28702 (1994).
(
10.1016/S0021-9258(19)61962-9
) / J. Biol. Chem. by Leteurtre F. (1994) - The reconstituted enzyme was prepared by incubating crude nuclear extracts containing the 58-kD core domain (expressed in insect cells) with the immobilized glutathione-S-transferase (GST)–COOH-terminal domain fusion protein (expressed in E. coli ) (16). The reconstituted core plus COOH-terminal enzyme was liberated by factor Xa cleavage. The reconstituted human topo I was separated from factor Xa and any free GST or COOH-terminal domain by POROS SP20 chromatography as described (16). DNA oligonucleotides were synthesized by DNA express (Fort Collins CO) and purified as described (11). Oligonucleotides that contained a 5′-bridging phosphorothioate linkage at the site of topo I cleavage were synthesized according to Burgin et al. (34) where 5′-( S -trityl)-mercapto-5′-deoxythymidine-3′- O -(2-cyanoethyl- N N -diisopropylamino)phosphite was used for the synthesis of the +1 nucleotide in the cleaved strand of the high-affinity topo I binding site from T. thermophilus (19). Duplex oligonucleotides were prepared by mixing equimolar concentrations of complementary strands each at a final concentration of 0.1 mM in the presence of 6 mM NaCl. Annealing of the two strands was achieved by slow cooling from 80°C to room temperature over a period of 8 hours.
-
Burgin A. B., Huizenga B. N., Nash H. A., Nucleic Acids Res. 23, 2973 (1995).
(
10.1093/nar/23.15.2973
) / Nucleic Acids Res. by Burgin A. B. (1995) 10.1016/S0076-6879(97)76073-7
-
Holm L., Sander C., Nucleic Acids Res. 25, 231 (1997).
(
10.1093/nar/25.1.231
) / Nucleic Acids Res. by Holm L. (1997) -
Klemm J. D., Rould M. A., Aurora R., Herr W., Pabo C., Cell 77, 21 (1994).
(
10.1016/0092-8674(94)90231-3
) / Cell by Klemm J. D. (1994) - Hickman A. B., Waninger S., Scocca J. J., Dyda F., ibid. 89, 227 (1997). / ibid. by Hickman A. B. (1997)
-
Esposito D., Scocca J. J., Nucleic Acids Res. 25, 3605 (1997);
(
10.1093/nar/25.18.3605
) / Nucleic Acids Res. by Esposito D. (1997) - ; HP1 integrase also uses a transient 3′-phosphate-tyrosine intermediate during its catalytic cycle of integration and excision of the phage DNA and is representative of the family of bacteriophage integrases.
- Jaxel C., Kohn K. W., Wani M. C., Wall M. E., Pommier Y., Cancer Res. 49, 1465 (1989); / Cancer Res. by Jaxel C. (1989)
-
Tanizawa A., Kohn K. W., Kohlhagen G., Leteurtre F., Pommier Y., Biochemistry 34, 7200 (1995).
(
10.1021/bi00021a035
) / Biochemistry by Tanizawa A. (1995) -
Crow R. T., Crothers D. M., J. Med. Chem. 35, 4160 (1992).
(
10.1021/jm00100a022
) / J. Med. Chem. by Crow R. T. (1992) - Wall M. E., et al., ibid. 36, 2689 (1993). / ibid. by Wall M. E. (1993)
-
K. Lackey et al. ibid. 38 906 (1995)
(
10.1021/jm00006a008
) - W. D. Kingsbury et al. ibid. 34 98 (1991).
-
Tanizawa A., Kohn K. W., Pommier Y., Nucleic Acids Res. 21, 5157 (1993);
(
10.1093/nar/21.22.5157
) / Nucleic Acids Res. by Tanizawa A. (1993) -
Kjeldsen E., et al., J. Mol. Biol. 202, 333 (1988).
(
10.1016/0022-2836(88)90462-7
) / J. Mol. Biol. by Kjeldsen E. (1988) -
Pommier Y., et al., Proc. Natl. Acad. Sci. U.S.A. 92, 8861 (1995).
(
10.1073/pnas.92.19.8861
) / Proc. Natl. Acad. Sci. U.S.A. by Pommier Y. (1995) - McPhail A. T., Sim G. A., J. Chem. Soc. B, 923 (1968). / J. Chem. Soc. by McPhail A. T. (1968)
- Z. Otwinowski and W. Minor Eds. Data Collection and Processing (Daresbury UK 1993).
- Z. Otwinowski in ibid. pp. 80–86.
- K. Cowtan Joint CCP4 and ESF-EACBM Newslett. Protein Crystallogr. 31 34 (1994).
- Abrahams J. P., Leslie A. G. W., Acta Crystallogr. D52, 30 (1996). / Acta Crystallogr. by Abrahams J. P. (1996)
- Jones T. A., Zou J.-Y., Cowan S. W., ibid. A47, 110 (1991). / ibid. by Jones T. A. (1991)
-
J. Navaza ibid. A50 157 (1994).
(
10.1107/S0108767393007597
) - A. T. Brunger X-PLOR (Version 3.1): A System for X-ray Crystallography and NMR (Yale Univ. Press New Haven CT 1993).
-
___, J. Mol. Biol. 203, 803 (1988).
(
10.1016/0022-2836(88)90211-2
) / J. Mol. Biol. by ___ (1988) -
___, Nature 355, 472 (1992).
(
10.1038/355472a0
) / Nature by ___ (1992) 10.1107/S0108767386099622
-
Moore J. M., Chazin W. J., Powls R., Wright P. E., Biochemistry 27, 7806 (1988).
(
10.1021/bi00420a033
) / Biochemistry by Moore J. M. (1988) 10.1107/S0021889891004399
-
Bacon D. J., Anderson W. F., J. Mol. Graphics 6, 219 (1988);
(
10.1016/S0263-7855(98)80030-1
) / J. Mol. Graphics by Bacon D. J. (1988) - Merritt E. A., Murphy M. E. P., Acta Crystallogr. D50, 869 (1994). / Acta Crystallogr. by Merritt E. A. (1994)
10.1002/prot.340110407
10.1093/protein/6.1.37
-
Joshua-Tor L., et al., J. Mol. Biol. 225, 397 (1992).
(
10.1016/0022-2836(92)90929-E
) / J. Mol. Biol. by Joshua-Tor L. (1992) - We thank S. Turley E. Pohl S. Suresh B. Bernstein A. Ævarsson D. Chudzik J. Yeh F. Athappilly F. van den Akker C. Verlinde and many other members of the Biomolecular Structure Center at the University of Washington for technical assistance and intellectual support. We also thank the staffs of the Stanford Synchrotron Radiation Laboratory the Brookhaven National Laboratory the Cornell High Energy Synchrotron Source and the European Synchrotron Radiation Laboratory for their extensive support with data collection. Thanks are also due to A. Burgin for advice on the synthesis of oligonucleotides containing a 5′-bridging phosphorothioate and to DNA Express (Fort Collins CO) for conducting the syntheses. Supported by American Cancer Society grant PF-3905 (L.S.) grant GM49156 from the National Institutes of Health (J.J.C.) by a major equipment grant from the Murdock Charitable Trust to the Biomolecular Structure Center and grant NCI CA65656 from the National Institutes of Health (W.G.J.H.). The Stanford Synchrotron Radiation Laboratory is founded by the Department of Energy (BES OBER) and the NIH (NCRR).
Dates
Type | When |
---|---|
Created | 23 years, 1 month ago (July 27, 2002, 5:42 a.m.) |
Deposited | 1 year, 7 months ago (Jan. 12, 2024, 9:53 p.m.) |
Indexed | 5 days, 17 hours ago (Aug. 30, 2025, 12:38 p.m.) |
Issued | 27 years, 5 months ago (March 6, 1998) |
Published | 27 years, 5 months ago (March 6, 1998) |
Published Print | 27 years, 5 months ago (March 6, 1998) |
@article{Redinbo_1998, title={Crystal Structures of Human Topoisomerase I in Covalent and Noncovalent Complexes with DNA}, volume={279}, ISSN={1095-9203}, url={http://dx.doi.org/10.1126/science.279.5356.1504}, DOI={10.1126/science.279.5356.1504}, number={5356}, journal={Science}, publisher={American Association for the Advancement of Science (AAAS)}, author={Redinbo, Matthew R. and Stewart, Lance and Kuhn, Peter and Champoux, James J. and Hol, Wim G. J.}, year={1998}, month=mar, pages={1504–1513} }